Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
|
|
|
9.
|
|
|
|
10.
|
|
|
|
11.
|
|
|
|
12.
|
|
|
|
13.
|
Small molecule inhibition of the CBFβ/RUNX interaction decreases ovarian cancer growth and migration through alterations in genes related to epithelial-to-mesenchymal transition. [electronic resource] by
- Carlton, Anne L
- Illendula, Anuradha
- Gao, Yan
- Llaneza, Danielle C
- Boulton, Adam
- Shah, Anant
- Rajewski, Roger A
- Landen, Charles N
- Wotton, David
- Bushweller, John H
Producer: 20180711
In:
Gynecologic oncology vol. 149
Availability: No items available.
|
|
|
14.
|
|
|
|
15.
|
A second-generation 2-Methoxyestradiol prodrug is effective against Barrett's adenocarcinoma in a mouse xenograft model. [electronic resource] by
- Kambhampati, Suman
- Rajewski, Roger A
- Tanol, Mehmet
- Haque, Inamul
- Das, Amlan
- Banerjee, Snigdha
- Jha, Saheli
- Burns, Douglas
- Borrego-Diaz, Emma
- Van Veldhuizen, Peter J
- Banerjee, Sushanta K
Producer: 20131017
In:
Molecular cancer therapeutics vol. 12
Availability: No items available.
|
|
|
16.
|
Engineering an antibiotic to fight cancer: optimization of the novobiocin scaffold to produce anti-proliferative agents. [electronic resource] by
- Zhao, Huiping
- Donnelly, Alison C
- Kusuma, Bhaskar R
- Brandt, Gary E L
- Brown, Douglas
- Rajewski, Roger A
- Vielhauer, George
- Holzbeierlein, Jeffrey
- Cohen, Mark S
- Blagg, Brian S J
Producer: 20110817
In:
Journal of medicinal chemistry vol. 54
Availability: No items available.
|
|
|
17.
|
A tool compound targeting the core binding factor Runt domain to disrupt binding to CBFβ in leukemic cells. [electronic resource] by
- Oo, Zaw Min
- Illendula, Anuradha
- Grembecka, Jolanta
- Schmidt, Charles
- Zhou, Yunpeng
- Esain, Virginie
- Kwan, Wanda
- Frost, Isaura
- North, Trista E
- Rajewski, Roger A
- Speck, Nancy A
- Bushweller, John H
Producer: 20190318
In:
Leukemia & lymphoma vol. 59
Availability: No items available.
|
|
|
18.
|
Development of a high-throughput screening cancer cell-based luciferase refolding assay for identifying Hsp90 inhibitors. [electronic resource] by
- Sadikot, Takrima
- Swink, Megan
- Eskew, Jeffery D
- Brown, Douglas
- Zhao, Huiping
- Kusuma, Bhaskar R
- Rajewski, Roger A
- Blagg, Brian S J
- Matts, Robert L
- Holzbeierlein, Jeffrey M
- Vielhauer, George A
Producer: 20140528
In:
Assay and drug development technologies vol. 11
Availability: No items available.
|
|
|
19.
|
Chemical biology. A small-molecule inhibitor of the aberrant transcription factor CBFβ-SMMHC delays leukemia in mice. [electronic resource] by
- Illendula, Anuradha
- Pulikkan, John A
- Zong, Hongliang
- Grembecka, Jolanta
- Xue, Liting
- Sen, Siddhartha
- Zhou, Yunpeng
- Boulton, Adam
- Kuntimaddi, Aravinda
- Gao, Yan
- Rajewski, Roger A
- Guzman, Monica L
- Castilla, Lucio H
- Bushweller, John H
Producer: 20150305
In:
Science (New York, N.Y.) vol. 347
Availability: No items available.
|
|
|
20.
|
KU135, a novel novobiocin-derived C-terminal inhibitor of the 90-kDa heat shock protein, exerts potent antiproliferative effects in human leukemic cells. [electronic resource] by
- Shelton, Shary N
- Shawgo, Mary E
- Matthews, Shawna B
- Lu, Yuanming
- Donnelly, Alison C
- Szabla, Kristen
- Tanol, Mehmet
- Vielhauer, George A
- Rajewski, Roger A
- Matts, Robert L
- Blagg, Brian S J
- Robertson, John D
Producer: 20091217
In:
Molecular pharmacology vol. 76
Availability: No items available.
|